Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

TherapeuticsMD, Inc. (29TA.SG)

Compare
0.8450
0.0000
(0.00%)
As of 8:00:23 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,761
1,761
--
69,963
2,573
Cost of Revenue
--
--
--
1,397
1,402
Gross Profit
69,366
--
--
68,566
1,171
Operating Expense
5,253
5,253
--
57,903
80,748
Operating Income
-3,492
-3,492
--
10,663
-79,577
Net Non Operating Interest Income Expense
--
--
--
--
-32,917
Other Income Expense
1,149
1,149
--
-9,589
272
Pretax Income
-2,343
-2,343
--
1,074
-79,305
Tax Provision
-31
-31
--
--
--
Net Income Common Stockholders
-2,181
-2,181
--
111,997
-172,415
Diluted NI Available to Com Stockholders
-2,181
-2,181
--
111,997
-172,415
Basic EPS
-0.19
--
-0.98
12.41
-21.50
Diluted EPS
-0.19
--
-0.98
11.96
-21.50
Basic Average Shares
11,532
--
10,441
9,028
7,959.8400
Diluted Average Shares
11,532
--
10,441
9,366
7,959.8400
Total Operating Income as Reported
-4,760
-4,760
--
1,191
-79,577
Total Expenses
5,253
5,253
--
59,300
82,150
Net Income from Continuing & Discontinued Operation
-2,181
-2,181
--
111,997
-172,415
Normalized Income
-1,060.7768
-1,060.7768
--
10,546
-79,305
Interest Expense
--
--
--
--
22,568
Net Interest Income
--
--
--
--
-32,917
EBIT
-3,492
-3,492
--
10,663
-79,577
EBITDA
-2,983
-2,983
--
11,863
-78,841
Reconciled Cost of Revenue
--
--
--
1,390
1,402
Reconciled Depreciation
509
509
922
1,200
736
Net Income from Continuing Operation Net Minority Interest
-2,312
-2,312
--
1,074
-79,305
Total Unusual Items Excluding Goodwill
-1,268
-1,268
--
-9,472
--
Total Unusual Items
-1,268
-1,268
--
-9,472
--
Normalized EBITDA
-1,715
-1,715
--
21,335
-78,841
Tax Rate for Calcs
0
0
0
--
--
Tax Effect of Unusual Items
-16.7768
-16.7768
--
--
--
12/31/2021 - 10/1/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade